Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - folic acid, quantity: 5 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 01 jan 1991 : for the treatment of megaloblastic anaemia, where this has been shown to be due to folic acid deficiency either due to inadequate dietary intake, malabsorption or increased utilisation, including pregnancy and lactation, haemolytic anaemia, hyperthyroidism, exfoliative dermatitis and chronic infection, for prophylaxis during pregnancy and lactation.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sulthiame, quantity: 200 mg - tablet, film coated - excipient ingredients: purified talc; macrogol 4000; maize starch; lactose monohydrate; titanium dioxide; gelatin; hypromellose; colloidal anhydrous silica; magnesium stearate - indications as at 01 january 1991 : behavioural disorders associated with epilepsy; hyperkinetic behaviour; temporal lobe epilepsy; myoclonic seizures; grand mal attacks; jacksonian seizures.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sulthiame, quantity: 50 mg - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 4000; purified talc; gelatin; lactose monohydrate; magnesium stearate; maize starch; colloidal anhydrous silica - indications as at 01 january 1991 : behavioural disorders associated with epilepsy; hyperkinetic behaviour; temporal lobe epilepsy; myoclonic seizures; grand mal attacks; jacksonian seizures.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - oxytocin, quantity: 5 iu; ergometrine maleate, quantity: 0.5 mg - injection, solution - excipient ingredients: sodium chloride; maleic acid; water for injections; acetic acid; sodium acetate trihydrate; chlorobutanol hemihydrate - active management of the third stage of labour. prevention and treatment of post-partum haemorrhage associated with uterine atony.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - esmolol hydrochloride, quantity: 2500 mg - injection, powder for - excipient ingredients: - supraventricular tachycardia,brevibloc (esmolol hcl) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. brevibloc is also indicated in non compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. brevibloc is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - calcium gluconate monohydrate, quantity: 931 mg - injection, solution - excipient ingredients: calcium saccharate; water for injections - calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. it can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. iv injections have been used in the treatment of acute renal biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. they may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.54 mg (equivalent: bupivacaine hydrochloride, qty 100 mg); adrenaline (epinephrine) acid tartrate, quantity: 182 microgram (equivalent: adrenaline (epinephrine), qty 100 microgram) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium chloride; water for injections - bupivacaine 0.5% with adrenaline 1:200,000 phebra is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows:,surgical anaesthesia ? epidural block for surgery ? field block (minor and major nerve blocks and infiltration) analgesia ? intermittent bolus epidural administration for analgesia in postoperative pain or labour pain ? field block (minor nerve block and infiltration)

Australia - inglés - Department of Health (Therapeutic Goods Administration)

shiseido (australia) pty ltd - octyl methoxycinnamate,titanium dioxide -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - menthol, quantity: 7.14 mg; peppermint oil, quantity: 7.14 mg (equivalent: menthol, qty 3.57 mg) - lozenge - excipient ingredients: liquid glucose; sucrose; brilliant blue fcf - demulcent/soothe irritated tissues ; decongestant/relieve nasal congestion ; unblock/clear nasal passages ; decrease/reduce/relieve cough ; relieve dry throat ; decrease/reduce/relieve throat irritation ; decrease/reduce/relieve itchy throat ; relieve itchy throat ; relieve symptoms of sore throat/pharyngitis

Australia - inglés - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; purified talc; magnesium stearate; colloidal anhydrous silica; povidone; hyprolose; titanium dioxide; macrogol 8000; vanillin; basic butylated methacrylate copolymer - hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.